pharmaceuticals-and-healthcare

United States Antibody-drug Conjugates Market Report 2017


Published On : Aug 2017

Category : Pharmaceutical

No. of Pages : 103 pages

  • $3800
  • $7600

Please click below to avail discount on this report

In this report, the United States Antibody-drug Conjugates market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Antibody-drug Conjugates in these regions, from 2012 to 2022 (forecast).

United States Antibody-drug Conjugates market competition by top manufacturers/players, with Antibody-drug Conjugates sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
F. Hoffmann-La Roche
Seattle Genetics
Takeda Pharmaceuticals
AbbVie
AbGenomics
ADC Therapeutics
Agensys
ALMAC Group
Ambrx
Astellas Pharma

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Seattle Genetics technology
ImmunoGen technology
Immunomedics technology
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antibody-drug Conjugates for each application, including
IgG1 antibodies
HER2 antibodies

In the recent times, the global market for United states antibody drug conjugates market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of United states antibody drug conjugates market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the United states antibody drug conjugates market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the United states antibody drug conjugates market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of United states antibody drug conjugates market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for United states antibody drug conjugates market report 2017, including the definition, classification, and industry chain structure of United states antibody drug conjugates market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the United states antibody drug conjugates market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for United states antibody drug conjugates market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning United states antibody drug conjugates market report 2017, implemented in each of the geographical segments. The predominant applications of the United states antibody drug conjugates market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for United states antibody drug conjugates market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the United states antibody drug conjugates market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Antibody-drug Conjugates
Figure United States Antibody-drug Conjugates Market Size (MT) by Type (2012-2022)
Figure United States Antibody-drug Conjugates Sales Volume Market Share by Type (Product Category) in 2016
Figure Seattle Genetics technology Product Picture
Figure ImmunoGen technology Product Picture
Figure Immunomedics technology Product Picture
Figure United States Antibody-drug Conjugates Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Antibody-drug Conjugates by Application in 2016
Figure IgG1 antibodies Examples
Figure HER2 antibodies Examples
Figure United States Antibody-drug Conjugates Market Size (Million USD) by Region (2012-2022)
Figure The West Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antibody-drug Conjugates Sales (MT) and Growth Rate (2012-2022)
Figure United States Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antibody-drug Conjugates Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Antibody-drug Conjugates Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Antibody-drug Conjugates Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antibody-drug Conjugates Sales Share by Players/Suppliers
Figure 2017 United States Antibody-drug Conjugates Sales Share by Players/Suppliers
Figure United States Antibody-drug Conjugates Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Antibody-drug Conjugates Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Antibody-drug Conjugates Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antibody-drug Conjugates Revenue Share by Players/Suppliers
Figure 2017 United States Antibody-drug Conjugates Revenue Share by Players/Suppliers
Table United States Market Antibody-drug Conjugates Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Antibody-drug Conjugates Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Antibody-drug Conjugates Market Share of Top 3 Players/Suppliers
Figure United States Antibody-drug Conjugates Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antibody-drug Conjugates Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antibody-drug Conjugates Product Category
Table United States Antibody-drug Conjugates Sales (MT) by Region (2012-2017)
Table United States Antibody-drug Conjugates Sales Share by Region (2012-2017)
Figure United States Antibody-drug Conjugates Sales Share by Region (2012-2017)
Figure United States Antibody-drug Conjugates Sales Market Share by Region in 2016
Table United States Antibody-drug Conjugates Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Antibody-drug Conjugates Revenue Share by Region (2012-2017)
Figure United States Antibody-drug Conjugates Revenue Market Share by Region (2012-2017)
Figure United States Antibody-drug Conjugates Revenue Market Share by Region in 2016
Table United States Antibody-drug Conjugates Price (USD/Kg) by Region (2012-2017)
Table United States Antibody-drug Conjugates Sales (MT) by Type (2012-2017)
Table United States Antibody-drug Conjugates Sales Share by Type (2012-2017)
Figure United States Antibody-drug Conjugates Sales Share by Type (2012-2017)
Figure United States Antibody-drug Conjugates Sales Market Share by Type in 2016
Table United States Antibody-drug Conjugates Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Antibody-drug Conjugates Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibody-drug Conjugates by Type (2012-2017)
Figure Revenue Market Share of Antibody-drug Conjugates by Type in 2016
Table United States Antibody-drug Conjugates Price (USD/Kg) by Types (2012-2017)
Figure United States Antibody-drug Conjugates Sales Growth Rate by Type (2012-2017)
Table United States Antibody-drug Conjugates Sales (MT) by Application (2012-2017)
Table United States Antibody-drug Conjugates Sales Market Share by Application (2012-2017)
Figure United States Antibody-drug Conjugates Sales Market Share by Application (2012-2017)
Figure United States Antibody-drug Conjugates Sales Market Share by Application in 2016
Table United States Antibody-drug Conjugates Sales Growth Rate by Application (2012-2017)
Figure United States Antibody-drug Conjugates Sales Growth Rate by Application (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Seattle Genetics Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Seattle Genetics Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure Seattle Genetics Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Takeda Pharmaceuticals Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Takeda Pharmaceuticals Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure Takeda Pharmaceuticals Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AbbVie Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure AbbVie Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure AbbVie Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table AbGenomics Basic Information List
Table AbGenomics Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AbGenomics Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure AbGenomics Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure AbGenomics Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table ADC Therapeutics Basic Information List
Table ADC Therapeutics Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure ADC Therapeutics Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure ADC Therapeutics Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure ADC Therapeutics Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table Agensys Basic Information List
Table Agensys Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Agensys Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Agensys Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure Agensys Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table ALMAC Group Basic Information List
Table ALMAC Group Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure ALMAC Group Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure ALMAC Group Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure ALMAC Group Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table Ambrx Basic Information List
Table Ambrx Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ambrx Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Ambrx Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure Ambrx Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Astellas Pharma Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Astellas Pharma Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure Astellas Pharma Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody-drug Conjugates
Figure Manufacturing Process Analysis of Antibody-drug Conjugates
Figure Antibody-drug Conjugates Industrial Chain Analysis
Table Raw Materials Sources of Antibody-drug Conjugates Major Players/Suppliers in 2016
Table Major Buyers of Antibody-drug Conjugates
Table Distributors/Traders List
Figure United States Antibody-drug Conjugates Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Antibody-drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Antibody-drug Conjugates Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Antibody-drug Conjugates Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Antibody-drug Conjugates Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Antibody-drug Conjugates Sales Volume (MT) Forecast by Type in 2022
Table United States Antibody-drug Conjugates Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Antibody-drug Conjugates Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Antibody-drug Conjugates Sales Volume (MT) Forecast by Application in 2022
Table United States Antibody-drug Conjugates Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Antibody-drug Conjugates Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antibody-drug Conjugates Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antibody-drug Conjugates Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top